Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis.

Silicosis, an interstitial lung disease prevalent among miners, sand blasters, and quarry workers, is manifested as a chronic inflammatory response leading to severe pulmonary fibrotic changes. Proinflammatory cytokines, such as TNFalpha and IL-1, produced in the lung by type II epithelial cells and alveolar macrophages, have been strongly implicated in the formation of these lesions. Recently, a number of single nucleotide polymorphisms (SNPs), which quantitatively affect mRNA synthesis, have been identified in the TNFalpha promoter and IL-1 gene cluster and their frequency is associated with certain chronic inflammatory diseases. To assess the role of these SNPs in silicosis, we examined their frequency in 325 ex-miners with moderate and severe silicosis and 164 miners with no lung disease. The odds ratio of disease for carriers of the minor variant, TNFalpha (-238), was markedly higher for severe silicosis (4.0) and significantly lower for moderate silicosis (0.52). Regardless of disease severity, the odds ratios of disease for carriers of the IL-1RA (+2018) or TNFalpha (-308) variants were elevated. There were no significant consistent differences in the distribution of the IL-1alpha (+4845) or IL-1beta (+3953) variants with respect to disease status. In addition, several significant gene-gene and gene-gene-environment interactions were observed. Different associations between moderate cases and controls versus severe cases and controls were also observed in a number of these multigene comparisons. These studies suggest that gene-environment interactions involving cytokine polymorphisms play a significant role in silicosis by modifying the extent of and susceptibility to disease.

[1]  K. Leslie,et al.  Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages. , 1991, American journal of respiratory cell and molecular biology.

[2]  J. Mansfield,et al.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.

[3]  Martine A. Collart,et al.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis , 1990, Nature.

[4]  G. M. Ridder,et al.  Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. , 1990, American journal of respiratory cell and molecular biology.

[5]  C. Fiocchi,et al.  Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. , 1995, Journal of immunology.

[6]  A. Blakemore,et al.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. , 1994, The Journal of investigative dermatology.

[7]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[8]  Y. Palesch,et al.  Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. , 1998, Journal of clinical periodontology.

[9]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[10]  P. Borm,et al.  Spontaneous and stimulated release of tumor necrosis factor-alpha (TNF) from blood monocytes of miners with coal workers' pneumoconiosis. , 1988, The American review of respiratory disease.

[11]  J. Whitsett,et al.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. , 1995, The Journal of clinical investigation.

[12]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. , 1995, Arthritis and rheumatism.

[13]  J. Mansfield,et al.  TNF2, a polymorphism of the tumour necrosis‐α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype , 1996, European journal of immunology.

[14]  A. Allison The interleukin‐1 family of molecules , 1985, Bioessays.

[15]  G. Hunninghake,et al.  Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. , 1994, Experimental lung research.

[16]  W. Sterry,et al.  Tumor necrosis factor-alpha gene polymorphism in psoriasis. , 1997, Experimental and clinical immunogenetics.

[17]  H. Orr,et al.  Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. Gery,et al.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. , 1984, The Journal of clinical investigation.

[19]  G. Wagner Asbestosis and silicosis , 1997, The Lancet.

[20]  P. Carré,et al.  Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica. , 1996, Journal of immunology.

[21]  T. Sasazuki,et al.  Immunogenetic analysis of silicosis in Japan. , 1993, American journal of respiratory cell and molecular biology.

[22]  Song-Lih Huang,et al.  Tumor Necrosis Factor- α Gene Polymorphism in Chronic Bronchitis , 1997 .

[23]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[24]  J. Blackwell,et al.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis , 1995, The Journal of experimental medicine.

[25]  M. Petri,et al.  A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. , 1997, Arthritis and rheumatism.

[26]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[27]  C. Gordon,et al.  Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[28]  H. Mcdevitt,et al.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Boomsma,et al.  Genetic influence on cytokine production and fatal meningococcal disease , 1997, The Lancet.

[30]  F. Pociot,et al.  Monokine Antagonism Is Reduced in Patients With IDDM , 1994, Diabetes.

[31]  P. Miossec,et al.  Possible genetic association between interleukin-1alpha gene polymorphism and the severity of chronic polyarthritis. , 1999, European cytokine network.

[32]  A. Blakemore,et al.  Association of the interleukin one receptor antagonist gene polymorphism with lichen sclerosus , 1994 .

[33]  M. Cork,et al.  Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. , 1996, Dermatologic clinics.

[34]  K. Kornman,et al.  Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. , 1998, Annals of periodontology.